Pharming

  • Pharming announced its intention to acquire all North American commercialisation rights to RUCONEST┬« from Valeant
  • Funded through a combination of debt and new equity capital
  • Kempen & Co acted as financial advisor to the Board of Supervisory Directors of Pharming